C181 - Treatment of Pediatric Multiple Sclerosis in the Current Era

Event Time: Wednesday May 8, 2019 1:00 pm to 3:00 pm
Topic(s): Child Neurology and Developmental Neurology, MS and CNS Inflammatory Disease
Director(s): Brenda Banwell MD, FAAN
Description: This program will focus on recent advances in the care of children and teens with multiple sclerosis. Faculty will first review the 2017 diagnostric criteria for MS, outlining how these criteria apply in the pediatric MS context. The emerging recognition of myelin oligodendrocyte glycoprotein (MOG) antibodies in identifying pediatric patients with a non-MS clinical course will be highlighted. Following discussion regarding accurate diagnosis, faculty will then focus on treatment. The recent PARADIGMS trial, the first large-scale randomized clinical trial in pediatric MS, will be reviewed. An overview of ongoing clinical trials will be presented. An approach to clinical care will be demonstrated, including dosing and safety monitoring considerations. Finally, faculty will synthesize the current treatment landscape with discussion centered on strategies for early, effective, and evidence-based care for pediatric MS.
Completion Message: Attendees should feel competent in the approach to diagnosis of MS in children; will be provided with strategies to investigate disorders considered in the differential, in order to meet the requirement of "excluding other diagnoses" prior to conferring the diagnosis of MS; be able to discuss up-to-date information regarding currently available therapeutic agents for pediatric MS, including dosing and safety monitoring; and be informed regarding upcoming clinical trials for pediatric MS.
CME Credits: 2
Core Competencies: Patient Care, Medical Knowledge, Practice-Based Learning and Improvement

Ready to register for the 2019 AAN Annual Meeting?

Register Now

Related Courses